Alcon announced that it introduced the Systane iLux meibomian gland dysfunction (MGD) thermal pulsation system.
Geneva, Switzerland-based Alcon designed the all-in-one, handheld Systane iLux MGD thermal pulsation device with new imaging technology to capture infrared photos and HD video of the meibomian glands. The system allows patients to see the need for treatment, visualize their procedure and experience results in treating their dry eye condition in as little as one week.
Alcon said in a news release that the Systane iLux MGD thermal pulsation system expands its current dry eye treatment offerings and allows practitioners to tailor MGD treatment to the needs of each patient in just eight to 12 minutes.
Eye care professionals can customize heat and compression across each easy-to-use visualization treatment zone with the Systane iLux MGD system, Alcon added.
“Alcon is dedicated to the advancement of medical device technology and providing Eye Care Professionals (ECPs) with the tools needed to effectively treat their patients,” Alcon VP of U.S. Pharmaceutical and Dry Eye Fred Ellis said in the release. “With the Systane iLux2 MGD Thermal Pulsation System, ECPs will be able to further patient trust and confidence because seeing is believing.”